GB0917072D0 - Peptide analogues of glucagon for diabetes therapy - Google Patents

Peptide analogues of glucagon for diabetes therapy

Info

Publication number
GB0917072D0
GB0917072D0 GB0917072A GB0917072A GB0917072D0 GB 0917072 D0 GB0917072 D0 GB 0917072D0 GB 0917072 A GB0917072 A GB 0917072A GB 0917072 A GB0917072 A GB 0917072A GB 0917072 D0 GB0917072 D0 GB 0917072D0
Authority
GB
United Kingdom
Prior art keywords
glucagon
peptide analogues
diabetes therapy
diabetes
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0917072A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ulster University
Original Assignee
Ulster University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ulster University filed Critical Ulster University
Priority to GB0917072A priority Critical patent/GB0917072D0/en
Publication of GB0917072D0 publication Critical patent/GB0917072D0/en
Priority to PCT/EP2010/005943 priority patent/WO2011038900A2/en
Ceased legal-status Critical Current

Links

GB0917072A 2009-09-29 2009-09-29 Peptide analogues of glucagon for diabetes therapy Ceased GB0917072D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0917072A GB0917072D0 (en) 2009-09-29 2009-09-29 Peptide analogues of glucagon for diabetes therapy
PCT/EP2010/005943 WO2011038900A2 (en) 2009-09-29 2010-09-29 Peptide analogues of glucagon for diabetes therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0917072A GB0917072D0 (en) 2009-09-29 2009-09-29 Peptide analogues of glucagon for diabetes therapy

Publications (1)

Publication Number Publication Date
GB0917072D0 true GB0917072D0 (en) 2009-11-11

Family

ID=41350545

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0917072A Ceased GB0917072D0 (en) 2009-09-29 2009-09-29 Peptide analogues of glucagon for diabetes therapy

Country Status (2)

Country Link
GB (1) GB0917072D0 (en)
WO (1) WO2011038900A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI596110B (en) * 2011-09-23 2017-08-21 諾佛 儂迪克股份有限公司 Novel glucagon analogues
GB201214493D0 (en) * 2012-08-14 2012-09-26 Univ Ulster Therapies
WO2014170496A1 (en) 2013-04-18 2014-10-23 Novo Nordisk A/S Stable, protracted glp-1/glucagon receptor co-agonists for medical use
CN106536547A (en) 2014-06-04 2017-03-22 诺和诺德股份有限公司 GLP-1/glucagon receptor co-agonists for medical use
US20160151511A1 (en) 2014-12-02 2016-06-02 Antriabio, Inc. Proteins and protein conjugates with increased hydrophobicity
MY185334A (en) 2014-12-30 2021-05-06 Hanmi Pharm Ind Co Ltd Glucagon derivatives with improved stability
JOP20200119A1 (en) * 2015-01-09 2017-06-16 Lilly Co Eli Gip and glp-1 co-agonist compounds
MX2017014586A (en) 2015-06-04 2018-03-09 Antriabio Inc Amine pegylation methods for the preparation of site-specific protein conjugates.
BR112017028517A2 (en) 2015-06-30 2018-08-28 Hanmi Pharm. Co., Ltd. "pharmaceutical composition, vector, peptide, polynucleotide and isolated conjugate and composition"
AU2016382394B2 (en) 2015-12-31 2019-07-04 Hanmi Pharm. Co., Ltd. Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonist
TWI757305B (en) 2016-06-29 2022-03-11 南韓商韓美藥品股份有限公司 Glucagon derivative, a conjugate thereof, and a composition comprising the same, and a therapeutic use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5480867A (en) * 1993-12-29 1996-01-02 The Rockefeller University Glucagon analogs with serine replacements
US6677136B2 (en) * 2000-05-03 2004-01-13 Amgen Inc. Glucagon antagonists
AR036711A1 (en) 2001-10-05 2004-09-29 Bayer Corp PEPTIDES THAT ACT AS GLON-RECEPTOR AGONISTS AND AS GLUCAGON RECEPTOR ANTAGONISTS AND THEIR PHARMACOLOGICAL USE METHODS
WO2004007524A2 (en) 2002-07-17 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Bicyclic oligopeptides
US20050124550A1 (en) * 2003-06-18 2005-06-09 Peri Krishna G. Compounds that modulate the glucagon response and uses thereof
WO2008062457A2 (en) 2006-10-03 2008-05-29 Cadila Healthcare Limited Antidiabetic compounds
JP5771005B2 (en) * 2007-10-30 2015-08-26 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ Glucagon antagonist and compound showing GLP-1 agonist activity
WO2009058662A2 (en) * 2007-10-30 2009-05-07 Indiana University Research And Technology Corporation Glucagon antagonists

Also Published As

Publication number Publication date
WO2011038900A2 (en) 2011-04-07
WO2011038900A3 (en) 2011-06-23

Similar Documents

Publication Publication Date Title
GB0917072D0 (en) Peptide analogues of glucagon for diabetes therapy
AP3286A (en) Glucagon analogues
IL252058A0 (en) Peptide analogs of alpha-melanocyte stimulating hormone
ZA201206838B (en) Novel glucagon analogues
HK1203531A1 (en) Glucagon analogues
EP2328922A4 (en) Analogues of glucose-dependent insulinotropic polypeptide
AP2013006671A0 (en) Glucagon analogues
HRP20150557T1 (en) Acylated glucagon analogues
ZA201104592B (en) Glucagon analogues
ZA201104593B (en) Glucagon analogues
ZA201104591B (en) Glucagon analogues
EP2376520A4 (en) Insulin analogs
IL222778A0 (en) Diabetes therapy
HK1209344A1 (en) Truncated analogues of glucose-dependent insulinotropic polypeptide
EP2793932A4 (en) Ctp-based insulin analogs for treatment of diabetes
ZA201204308B (en) Insulin analogues with chlorinated amino acids
PL2496596T3 (en) Therapeutic peptides
EP2576612A4 (en) Insulin analogues
HK1220701A1 (en) Insulin like peptides
IL215245A0 (en) Use of nkp46 for preventing diabetes
ZA201003844B (en) Delivery of functional compounds
ZA201007911B (en) Processes for refolding of insulin
EP2478010A4 (en) Partial peptide of lacritin
GB2468757B (en) Method of screening a drug such as insulin secretagogue
EP2739303A4 (en) A novel method for peroral delivery of insulin and its analogues for therapeutic usage

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)